2nd Annual NextGen 2011: Super-Generics Strategies India conference

Date: 27-29 April 2011
Place: Mumbai, India,
Pupose: To deliver strategies and applications of super-generics.

Over 3 intensive days, you will:

1. Hear from the key regulatory authorities from India and overseas to help drive your local and export market strategies with ease

2. Capture the visionary insights of domestic and international pharma CEOs and understand how super-generics are driving their long-term growth aspirations

3. Compare the full spectrum of R&D techniques available to cost-effectively migrate established generic products to high-value super-generics
Highlights of the event include:

• Plenary Sessions - benefit from lively discussions around the future of the Indian pharma industry

• Multiple Tracks - choose the sessions of most significance to your function, and tailor-make your conference experience

• Panel Debates - take part in timely and controversial group discussions around the key hurdles facing the industry today and solutions for a prosperous path ahead

• Regulatory Seminar - gain clear guidance on how you can navigate a multitude of regulatory regimes and fast track your product approvals process

• Facilitated Networking - take advantage of frequent networking breaks, lunches, cocktail roundtable debates, and our 1:1 meeting facility

• Solution Zone - browse the adjoining product display area and identify new partners to help make your super-generics strategy a practical reality

To register, contact my colleague Pallavi at +91 (022) 4046 1466, email conferences@ubmindia.com or visit www.nextgen-in.com

Bitotech companies

1. Company Name : Alembic Limited

Address A. P. & M. P. Division Alembic Road Vadodara - 390 003
Phone 0265-280550 / 880
Fax 0265-282931
URL: www.alembic-india.co.in

2. Company Name : All India Biotech Association (AIBA)

Address "VIPSS Centre", 2, Local Shopping Centre, Block EFGH, Masjid
Moth, Greater Kailash-II, New Delhi - 110 048
Phone 011-6430546 / 0446
Fax 011-6469166
URL www.aibaonline.com and www.biotech-int.com

3. Company Name : Amersham Pharmacia Biotech Asia Pacific Ltd.

Address FF3, First Floor, Palani Center, 32, Venkatanarayan Road, T. Nagar,
Chennai - 600 017
Phone 044-434 0747
Fax 044 4323770
URL www.apbindia.com

4. Company Name : Aristo Pharmaceuticals Ltd.

Address 23-A, Shah Industrial Estate, Off Veera Desai Road, Andheri (W),
Mumbai - 400 053
Phone 022-6313619, 6313663, 6301326, 6336229
Fax 022-6313695
URL www.aristopharma.com

5. Company Name : Biotech Consortium India Limited

Address 5th Floor, Anuvrat Bhavan, 210, Deen Dayal Upadhyay Marg, New
Delhi - 110 002
Phone 011-3219064-67
Fax 011-3219063
URL www.biotech.co.in

6. Company Name : Biotech Equity Research Group

Address Sonawala Building, 2nd Floor, 25, bank Street Fort, Mumbai - 400023
Phone 022-2654676, 2665323
URL http://www.biotech.equitysearchcentre.com/

7. Company Name : BrainWave Bioinformatics Ltd.
Address MAC House, 4 Sardar Patel Road, Guindy, Chennai -32
Phone 91 44 2220 0890
Fax 91 44 0230 0194
URL www.brainwave.co.in

8. Company Name : Catalyst Pharma Consulting

Address 71, Dharam Jyot, A. B. Nair Road, Juhu, Mumbai - 400 049
Phone 022-6201018, 6244552
Fax 022-6202248
URL www.CatalystPharmaConsult.com

9. Company Name : Chaitanya Healthcare Ecom Ltd.

Address Biomix Network Ltd., Millennium Business Park, Unit 303, Bldg. 6,
Sector III, MIDC, Mahape, New Bombay - 400 709
Phone 022-7781108, 7781110 Fax 022-7781110

10. Company Name : Chemitech Foundation

Address 26, Maker Chambers VI, Nariman Point, Nariman Point, Mumbai - 400 021
Phone 022-2874758 / 59, 2851734 / 74
Fax 022-2870502
URL www.chemtechfoundation.org

11. Company Name : Colour-Chem Limited

Address Life Science & Electronic Chemicals Divisiion, Mumbai - Agra
Road, Balkum, Thane - 400 608
Phone 022-5345060, 5412479
Fax 022-5345949
URL www.clour-chem.com

12. Company Name : Diagnostic Systems Laboratories Inc.

Address 144, Udyog Bhavan, Sonavala Road, Goregaon (EAST), Mumbai -400 063
Phone 022-8716318
Fax 022-8717380
URL www.DSLabs-IN.com

13. Company Name : Dr. Reddy's Laboratories Ltd.

Address 7-1-27, Ameerpet, Hyderabad - 500 016
Phone 040-3731946 / 1958
Fax 040-3731995 / 9666
URL www.drreddys.com

14. Company Name : Dr. Sastri's Phytolabs

Address 25, Sri Venkateswara Colony , Lothkunta, Secunderabad - 500 015
Phone 7866625

15. Company Name : Excel Industries Limited

Address Environ-Biotech Division, Amboli Hill, Veera Desai Road, Andheri (West), Mumbai
Phone 022-6367697 / 98, 6316100
Fax 022-6310916
URL www.excelind.com

16. Company Name : Fermenta Biotech Ltd.

Address Opp. Vidyapeeth, S. V. Road, Majiwada, Thane (W)
Phone 022-5341693
Fax 022-5340901

17. Company Name : Frost & Sullivan

Address Industry Manager - Healthcare Practice, 5, Chunawala Estate, Kondivitta Road, Andheri (E), Mumbai - 400 059
Phone 022-8324705
Fax 022-8324713
URL www.frost.com

18. Company Name : Genhelic Bioinformatics Pvt. Ltd.

Address 8-2-541/m/b/2, Road No. 7, Banjara Hills, Hyderabad - 500 034
Phone 040-3358288, 6515655, 6512772
Fax 040-3357958

19. Company Name : Hi Tech Bio Laboratories

Address Survey No. 36/1/1, M. N. 199, Vadgaon Khurd, Pune - 411 041
Phone 020-4390419 / 4390977
Fax 020-4390978
URL www.htblindia.com

20. Company Name : International Centre for Genetic and Biotechnology

Address ICGEB Campus, P.O.Box: 10504, Aruna Asaf Ali Marg, New Delhi -110 067
Phone 011-6102317, 6189360
Fax 011-6162316
URL www.icgeb.res.in

21. Company Name : Jindal Solvent Extractions

Address Ramnagar Road, Kashipur - 244713, Udham Singh Nagar- Distt (Uttaranchal)
Phone 05947-78031, 78724
Fax 05947-75372

22. Company Name : Landpower Biotech Ltd.

Address 29 / 242, Ist Floor, Srinivasa Nagar (West), Hyderabad - 500 038
Phone 040-3731899, 6508467
Fax 040-3731899

23.Company Name : Life Science Technology

Address Alfa Laval (India) Limited, Mumbai - Pune Road, Dapodi, Pune - 411012
Phone 020-7107347, 4116347
Fax 020-7149113
URL http://www.bangalorebio.com/externalsite?http://www.alfalaval.com

24, Company Name : Lupin Limited

Address 159, C. S. T. Road, Kalina Santacruz (East), Mumbai - 400 098
Phone 022-6931001 , 6526391 / 6575 / 8350
Fax 022-6526092

25. Company Name : Malladi Research Center

Address 52, Jawaharlal Nehru Road, Guindy, Chennai - 600 097
Phone 2345881
Fax 2345884

26. Company Name : Nicholas Piramal India Limited

Address 100, Centre Point, Dr. Ambedkar Road, Parel, Mumbai - 400 012
Phone 022-4134653 Extn. 1620
Fax 022-4163787
URL www.nicholaspiramal.com

27. Company Name : Ocimum Biosolutions Ltd.

Address 404, Reliance Classic, Road No. 1, Banjara Hills, Hyderabad - 500034
Phone 040-6627200
Fax 040-6627205
URL www.ocimumbio.com

28. Company Name : Periyar Chemicals Limited

Address Industrial Assurance Building, Churchgate, Mumbai - 400 020
Phone 022-2820663
Fax 022-2811751

29. Company Name : Scigenics (India) Pvt. Ltd.

Address 18, Vasudevapuram, Triplicane, Chennai - 600 005
Phone 044-4928867 / 4929652
Fax 044-4928880 / 4929652
URL www.scigenics.com.

30. Company Name : Serum Institute of India

Address 212/2 Hadapsar Pune 411028
Phone 020-269993900
Fax 020-26993921
URL www.seruminstitute.com

31. Company Name : Shantha Biotechnics Pvt. Ltd.

Address 3rd floor, Serene Chambers Road, No. 7, Banjara Hills, Hyderabad -500 034
Phone 040-3548507, 040-3543010, 040-3608843
Fax 040-3548476
URL www.shanthabiotech.com

32. Company Name : Sisco Research Laboratories Pvt. Ltd.

Address 2 / F, Satam Indl. Estate, 'C' Wing, Dr. Cardinal Gracious Road, Chakala, Andheri (E), Mumbai - 400 099
Phone 022-8203882/ 8214005
Fax 022-8380998
URL www.srlchem.com

33. Company Name : VARDA Biotech (P) Ltd.

Address # 209, Kartik Complex, New Link Road Andheri ( W), Mumbai - 400053
Phone 22-5693 5686 / 2673 0141
Fax 22-5693 5687
URL www.vardabiotech.com

34. Company Name : Yashraj Biotechnology Ltd.

Address Plot. No. C-232, TTC IND. AREA, MIDC, Navi Mumbai - 400 705
Phone 022-7686226 / 6285
Fax 022-7686087
URL www.yashraj.com

The Regional Centre for Biotechnology (RCB)

The Regional Centre for Biotechnology (RCB) is a newly established  institution of education, training and research in the National Capital Region (NCR) of Delhi by the Department of Biotechnology, Government of India under the auspices of UNESCO. RCB is designed to be a centre of excellence in biotechnology with intimate contributions from the countries of the region and academic institutions from the rest of the world. It provides a meeting place where innovation, enterprise and industrial development will germinate.

The Centre invites young scientists having Ph.D. degree in any discipline of science and who are below the age of 35 years to work in the areas related (but not limited) to structural, systems, and chemical biology, biomaterials and nano science and technology, cellular and molecular biology, disease biology and drug discovery.

Those likely to complete their Ph.D. degree in the next three months are also eligible to apply. The award shall be initially for the duration of three years, which may be extended for two more years subject to satisfactory progress, based on a review by a committee of experts. The award carries a consolidated stipend of Rs 40,000 per month. The awardee shall not be entitled to draw any other fellowship or salary.

Interested candidates may submit their application by filling the application form available on the RCB website (www.rcb.res.in), one page write-up of research interests, and a demand draft of Rs 500, in favour of Executive Director, Regional Centre for Biotechnology, Gurgaon 122 016. Copy of the application should be sent by registered post to: The Registrar, Regional Centre for Biotechnology, 180 Udyog Vihar Phase I, Gurgaon 122 016, India so as to reach by 31 December 2010.

Biotechnology Industry Organization (BIO)

About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtech NOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtech NOW

The Advanced Biofuels & Climate Change Information Center presents the latest commentary and data on the environmental and other impacts of biofuel production. Drop in and add your comments, at http://biofuelsandclimate.wordpress.com/

Upcoming BIO Events
Pacific Rim Summit on Industrial Biotechnology and Bioenergy
December 11-14, 2010
Honolulu, HI 

BIO Asia International Partnering Conference
January 24-25, 2011
Tokyo, Japan

BIO CEO & Investor Conference
February 14-15, 2011
New York, NY 

BIO-Europe Spring 2011
March 14-16, 2011
Milan, Italy 

BIO International Convention
June 27-30, 2011
Washington, DC


Biotechnology Industry Organization (BIO)
Paul Winters, 202-962-9237

Summit on Industrial Biotech and Bioenergy

BIO to Host Synthetic Biology Workshop at 2010 Pacific Rim Summit on Industrial Biotech and Bioenergy

 The Biotechnology Industry Organization (BIO) today announced a specialized workshop on advancements in synthetic biology that will highlight a new effort called the BIOFAB: International Open Facility Advancing Biotechnology, which aims to produce thousands of free, standardized DNA parts.

Speakers at the Advancements in Synthetic Biology & BIOFAB workshop will include:
  • Dr. Drew Endy, Stanford Professor of Bioengineering & Director, BIOFAB;
  • Dr. Vivek Mutalik, UC Berkeley Professor of Bioengineering & Team Leader, BIOFAB;
  • Holly Million, Executive Director, The BioBricks Foundation. 

The workshop will take place Sunday, Dec., 12, 2010, 10:00 a.m. to 11:30 a.m. in the Hibiscus Suite at the Hilton Hawaiian Village Beach Resort and Spa and is open to all registered attendees at BIO’s Pacific Rim Summit on Industrial Biotechnology and Bioenergy.

For more information on the conference, please visit http://www.bio.org/pacrim.

For assistance, please contact pacrim@bio.org or 202-962-9200.

National Conference on Metabolomics, Transcriptomics and Proteomics

January 29-30, 2011

Venue: Money Mounta Complex, Near SGPGI, Lucknow
First National Conference on Metabolomics, Transcriptomics and Proteomics (NCMTP-2011) to be held at Money Mounta Complex, Near SGPGI, Lucknow from January 29th to 30th, 2011.

Today, Metabolomics and Transcriptomics are amongst the most favorite and deeply researched areas of life science. The mRNA expression profiling and the study of small molecules’ metabolite profiles are combined to provide the instantaneous snapshots of physiology of the cell. They have some very important applications in functional genomics, Nutrigenomics and toxicity assessment. Moreover, systems biology and functional genomics are facing the challenge to integrate the wide variety of information from the metabolomics, transcriptomics along with proteomics.

NCMTP-2011 is the first National conference on the Metabolomics, Transcriptomics and Proteomics in Lucknow. It will be an opportunity for the National community to exchange ideas and develop a common vision for the future of research & development and healthcare. Contribution to the progress of developing a global Biotechnology and Bioinformatics society will include scientific papers demonstrations, poster Presentation and opinion/future vision papers. The organizing committee have been working to make NCMTP-2011 a truly memorable experience for all participants.

We sincerely hope that you will join us in making NCMTP-2011 a success. On behalf of the organizing committee, I am honored to welcome you to NCMTP-2011.

Conference Themes

The Conference Program will consist of introductory Plenary Keynote Presentations and Invited Guest Lectures. Six Invited Guest Lectures and 20 speakers will deliver oral presentation i.e. selected by our organizing Committee. A Poster Session, to be incorporated in the conference program, will allow individual participants to present Research papers. Abstracts of these papers will be made available to the Chairpersons of thematic sessions as appropriate, and will eventually be published.

Call for PapersAbstracts are invited for the papers and posters for the presentation during the conference are invited from the students, research scholars, faculties, R & D personnel, academicians etc.

The abstract of the paper should be sent to the convener of the conference, and it should not be more than 1000 words, typed in 12 Times New Roman with one and half spacing including the title of the paper, name of the authors and address for correspondence (including e-mail id). The paper must be reviewed by atleast two reviewers and you have to send their references along with abstract. After the scrutiny and selection of the papers, the authors will be intimated and then they should send the full text paper according to the guidelines given to them. The abstract should indicate the novel research work undertaken by the researcher.

Process of Selection

The program committee will evaluate papers and posters based on quality and relevance. All submissions are held in confidentiality prior to publication in the proceedings. Submissions received after the deadline will not be considered unless an extension has been granted by the program chairs. Accepted papers will be presented by their author(s) and will be published in the conference proceedings.

How to submit

Format of the abstract: totally 1-2 pages of A4 size, around 400-1000 English words in Times New Roman type including the title, authors, the authors’ institutions, summary of your research and 5-8 keywords.

Guidelines for Poster Presentation:

There will be poster session on Conference during Lunch and Tea break. Authors presenting posters are requested to be available for answering the questions during poster display.

• The Poster size should be max. 1.30 m (130 cm) high x 0.90 m (90 cm) wide.

• The figures and tables should be clear and the content of the poster should be

understandable by reading.

• Do not over load the poster as more material may mean less communication.

• Posters accepted will be assigned numbers. Please consult the program and time for

poster display.

The abstract/posters can be directly sent to the Conference Convener.

Awards/PrizeBest three oral papers and five posters will be awarded.

Conference Benefits

FIRST conferences promote National coordination and cooperation among Biotechnology & Bioinformatics community. It provides a forum for sharing goals, ideas, and information on how to improve research & development and healthcare. The two-day event is comprised of presentation sessions where the most recent security issues will be discussed.

At the conference you will:

Learn the latest R&D strategies

Gain technical solutions to Research problems

Keep up-to-date with the latest incident response and prevention

Gain insight on analyzing network vulnerability and computer vulnerabilities

Hear how the industry experts manage their security issues

Meet colleagues from around the world and exchange ideas and advice

Registration Enquiries and Further Information

The details of the programme are given in the brochure (attached) and also you can visit our conference website www.ncmtp.co.in . Online registration can be done, however the registration will be confirmed only after we receive the DD towards Registration fee.

Convener, NCMTP – 2011 1/179, Vineet Khand ,

Opposite Jaipuria Institute of Management,

Gomti Nagar, Lucknow.

Uttar Pradesh – 227106Ph No: 0522- 4073113 (O)

Mobile: 09936011461, 09565657406

Email id: ncmtp2011@gmail.com

Website: http://www.ncmtp.co.in

Biotech & Pharmaceutical Patenting Conference 2011

Venue: Westin Grand Munich
            Arabella park

Address: Arabellastrasse 6,
                  Munich, Germany

 Registration: Dec 10,2010

Organization: Informa Life Sciences, InformaEmailregistrations@informa-ls.com

CategoriesBusiness: Legal, Quality assurance, Health: Pharma, Science: Life Sciences / Biology, Technology: Biotechnology

Annual International Conference on Advances in Biotechnology (BIOTECH 2011)

28 February 2011 to 1 March 2011
Singapore, Mandarin Orchard Hotel, Singapore, Singapore

Website: http://www.advbiotech.org/index.html
Contact name: Conference Secretariat

The Conference Proceedings will be indexed by SCIrus and EBSCO, amongst others. In addition, they will be submitted to EI Compendex, and ISTP for indexing / inclusion subject to acceptence / approval.
Organized by: Global Science and Technology Forum

Deadline for abstracts/proposals: 29 December 2010

Check the event website for latest details.

Bio-IT World Conference & Expo

Apr 12-14, 2011 / Boston, UNITED STATES


Biotech conference held at PU

“There is a need for better interaction between academic institutions and industry in order to bridge the gap between the human resources available and industry requirements and have better career opportunities. Also, for the implementation of research, the academic institutions should have a commercial approach towards research undertaken by the scholars and professionals rather than mere academic accomplishments,” shared Ravi C Dasgupta, vice president-Group HR, Biocon Limited. 

The three day Biotechnica Chandigarh-2010 at Panjab University concluded with a panel discussion comprising eminent personalities including Dr G N Qazi, Prof R C Sobti, Ravi Das Gupta, Vineet Kalia, Dr Parkishit Bansal and Dr Sitaram Kumar on “Career Opportunities in Biotechnology”. 

Dr Parikshit Bansal from NIPER, Mohali delivered a lecture on the case studies of IPR issues in biotechnology and Ravi Das Gupta, Vice President, BIOCON, Banglore elaborated upon the entrepreneurship development and career opportunities in biotechnology. Dr G N Qazi, Vice Chancellor, Jamia Hamdard University and Former Director RRL, Jammu motivated the young biotechnologists with his hearty talk on the “Biotechnology from my heart”. Vineet Kalia, Senior Director, Dr Reddy’s Lab emphasized on the need of biotechnology as career and pointed out the shortage of sufficient number of good biotechnologist in the country to cater the industrial and academia needs.

WCS Research Fellowship Program

WCS Research Fellowship Program

United States

OrganizerWildlife: Conservation Society(Research Organisation)

Important Dates

Start Date: 16 November 2010

End Date : 5 January 2011

Deadline: 5 January 2011

Eligibility Undergrad Level

Type of Opportunity Scholarship/Fellowship

The WCS Research Fellowship Program (RFP) is a small grants program administered by the Wildlife Conservation Society (WCS) Institute that is designed to build capacity for the next generation of conservationists by supporting individual field research projects that have a clear application to the conservation of threatened wildlife and wild places. The RFP helps train applied conservation scientists from developing countries. Since the RFP's establishment in 1993, over 2,000 proposals totaling over $23 million have been submitted to WCS for funding, of which 300 proposals totaling more than $3 million have been funded. Over 60% of the total funded proposals have come from national conservationists (citizens of the country in which they are conducting their research). All grantees are graduate-level students pursuing masters, doctoral, or veterinary degrees (or equivalents). Collectively, these professionals will help to apply field-tested conservation science to the challenges facing conservation today. WCS seeks projects that are based on sound and innovative conservation science and that encourage conservation practices that can contribute to sustainable development.

Before you apply, we strongly recommend that you send a one-paragraph summary of your intended proposal to fellowship@wcs. org for review and feedback. Please be sure to include the topic of your study (species, place, challenge) and any questions you may have about whether you fulfill the applicant eligibility requirements. Visit the given webpage to see eligibility requirements.

Website : http://www.wcs.org

Website of Opportunity: http://programs.wcs.org/Default.aspx?alias=programs.wcs.org/grants

Biotechnology Entrepreneur Student Team

Biotechnology Entrepreneur Student Team (BEST): Applications Open

BEST-India (Biotechnology Entrepreneurship Student Teams) is aimed at encouraging young postgraduate and doctoral students in developing biotechnology entrepreneurship and exposing them to issues involved in commercialization of bio-science.

BEST is sponsored by the Department of Biotechnology

(www.dbtindia.nic.in), Ministry of Science and Technology, Government of India and is administered by ABLE – India (www.ableindia.org) 

Important Dates

Call of Proposal Open : 20th November 2010
Last date of uploading concept notes : 18 January 2011
First Level Screening of Proposals :1st February to 15 March 2011
Second Level Screening for 20 teams : 25 March to 25 May 2011
Announcement of Shortlisted 20 teams : 1 st June 2011
Entrepreneurship Workshop : 26 July to 29 July 2011


Applicants must be students who are pursuing their masters (including 5 year integrated post graduate degree), doctoral degree, BE or B Tech courses or four year professional courses in the area of life sciences (bioscience/biotechnology and/or related subjects) from Indian Universities/Institutes.

The applicants should form a team of 5 students and nominate a team leader. The individual team members may or may not br from the same institute/University. One third of the team members can be from disciplines other than life sciences.
Each team will submit only one entry.
Core biotechnology disciplines under which Concept Notes will be invited include Agriculture, Aquaculture, Alternate Energy/Bio-energy, Bioinformatics, Biological Applications, Bioprocess Engineering, Environment, Food, Human Resource Development, Medical, Medical Diagnostics, Medical devices, Medical Therapeutics, Nanotechnlogy/Nanobiotechnology, and Vaccines.
The proposals could be either for product, service or an application.

Concept Note Structure

The components of the concept notes are given below.
1. Executive Summary (max. 800 Words not exceeding 100 KB)
2. Concept Note (Not exceeding 500KB)
* Concept note title
* Concept and Description of Scientific Ideas
* Market Potential and Commercialization prospects
* Current challenges and roadblocks in the development of the project


The winning teams will be presented with cash awards at ABLE’s BioInvest Conference. The awards are sponsored by DBT.
The 1st Prize will be Rs. 500,000/-,
The 2nd Prize will be Rs. Rs. 300,000/- and
The 3rd Prize will be Rs. 200,000/-.

Conference Displays Stem Cell Research From Across Nation

Research covers facets of skin and hair disorders, hearing loss, and disease treatment

November 3, 2010

“Hearing loss is highly prevalent in our population – certainly something we all begin to experience with age, but I always tell my students: be careful about turning up the volume to high on your iPod. Damage to auditory cells in humans and mammals … is irreparable.” These were the opening words of a speech given by Prof. Andrew Bass, neurobiology and behavior, at the Third Annual Stem Cell Symposium held on Oct. 30. Bass concluded by saying that stem cells are just clearly beginning to make an impact on research to improve hearing loss.

The conference’s opening remarks were given by David Anders, New York State Stem Cell Science (NYSTEM) scientific officer. Dr. Anders explained that NYSTEM was implemented in 2007 with $600 million and an 11-year commitment to advance scientific discoveries in stem cell biology. The mission of the program is “to foster a strong stem cell research community in New York State and to accelerate the growth of scientific knowledge about stem cell biology and the development of therapies and diagnostic methods under the highest ethical, scientific and medical standards for the purpose of alleviating disease and improving human health.”

The morning session of the conference began with Prof. Richard Young, biology, MIT. Young is a member of the Whitehead Institute for Biomedical Research, and his work examines how protein regulators control gene expression in healthy and diseased cells. Dr. Young’s lab discovered that “embryonic stem cell master transcription factors form an interconnected autoregulatory loop, and thus feedback regulates their own expression.”

Young’s research is based on the concept that defects in gene expression can cause several chronic diseases, including “diabetes, cancer, hypertension, immune deficiencies and neurological disorders. Improved understanding of this circuitry should lead to new insights into disease mechanisms and the development of new diagnostics and therapeutics.”

Dr. Angela Christiano, the director of the Center of Human Genetics at Columbia University, discussed the application of stem cell technologies to skin and hair disorders.

Christiano studies genes that cause diseases through modeling a knockout of the gene in mice to test the effect of the gene. She discussed how Induced pluripotent stem (iPS) cells – cells with the potential to differentiate into multiple types of tissue – can be generated from an individual human dermal fibroblast.

The basic use of this technology has been around for about 30 years, explained Christiano – this is the same principle used to grow in vitro skin for patients with large burns. However, in her research, Christiano used this technique to grow keratinocytes – the predominant cell type in the epidermis – for patients. Her work examined genetic disorders that cause blistering of the skin by identifying their genes and finding the threshold expression at which the skin disorder would manifest. Christiano’s work has also lead to the discovery of several key genes involved in hair growth.

Following the morning session, 19 students from the University presented their work at a poster session. Samantha J. Palmaccio ’11 presented her poster, “Reconstruction of the MIR-376B-CIAP1 Pathway Targets Mammary Cancer Stem Cells,” which focused on “tumor-initiating, tumor propagating or cancer stem cells representing a subpopulation of highly tumorigenic. self-renewing cells believed to be largely responsible for tumor formation and progression in a broad variety of cancers.” The discovery of such cells is of vital importance since they are able to form carcinomas earlier and are able to reconstitute all tumor cell populations more efficiently, explained Palmaccio.

In the afternoon, Prof. Amy Wagers, stem cell and regenerative biology, Harvard University, presented on skeletal muscle stem cells in the muscle pepair and muscle disease. Her research focuses on “defining the factors and mechanisms regulating the migration, expansion and regenerative potential of blood-forming and muscle-forming stem cells.”

Prof. Alexander Nikitin, biomedical sciences, also presented his work. He is leader of the University’s stem cell research program. His work revealed that “both carcinomas and sarcomas associated with deficiency of tumor suppressor genes p53 and Rb arise from the stem cell compartment.”

Nikitin and Prof. Julien Sage, genetics, Stanford, both presented research that showed a side of stem cells applications that had not been investigated before. Stem cells have always been the center of fighting disease because of its applications to tissue regeneration. Now, these scientists have discovered that stem cells are involved in much more than creation and regeneration of healthy tissues; they are also involved in the originations of malignant ones.

Tudorita Tumbar, molecular biology and genetics, was chair of the Stem Cell Symposium Committee. Tumbar explained that the participants of the symposium were selected because they represented the leading edge of their field. Tumbar explained that it is important for the University to see what other people on campus and around the country are doing.

By Yusnier Sonora Lopez

JNCASR Summer Research Fellowship 2011

Jawaharlal Nehru Centre for Advanced Scientific Research(Research Organisation)

Deadline: 31 December 2010

Eligibility: Undergrad Level,Grad Level,Postgrad Level

Type of Opportunity: Scholarship/Fellowship

The JNCASR was established in 1989 by the Department of Science and Technology, Govt. of India. Its main objective is to promote scientific research at the highest level in frontier and interdisciplinary areas of science and Engineering. Summer Research Fellowships Programme is offered by JNCASR in association with Department of Science and Technology and Rajiv Gandhi Foundation, New Delhi. Around 120 Fellowships are awarded each year. Advertisements calling for applications to this programme appear during the month of September last week every year in national newspapers.

Research Areas:

Life Sciences : infections diseases, bioinformatics, developmental biology, biochemistry, molecular biology, genetics, life-history evolution, immunology, circadian biology, animal behavior, behavioral ecology, population ecology, evolutionary genetics, experimental evolution.

Chemical Sciences : solid state shemistry, inorganic and physical chemistry, organic chemistry, theoretical quantum chemistry, computer simulations of materials.

Physical Sciences : elementary particle and nulcear physics, relativity and cosmology, condensed matter and statistical physics, semiconductor physics, materials physics, astronomy and astrophysics, laser cooling of atoms, biophysics.

Engineering Sciences : turbulence, stability of fluid flows, two phase flow, experimental fluid mechanics, thermal science, biochemical engineering, polymer engineering, chemical reactor analysis, transport phenomena, interfacial phenomena, process metallurgy, physical metallurgy, ceramics, composite materials, computational biology, signal processing


Atmospheric Sciences : atmospheric boundary layer, near-surface environment, radiation, solar-terrestrial relations, monsoon dynamics, modeling


Science: Students studying in I, II or III year B. Sc., B. V. Sc., M. B. B. S., B. Pharma., and I and II year of M. Sc. course.

Engineering: Students studying in II and III year of B. E. and B.Tech can apply.

Selected students will be given an opportunity to pursue a research project with faculty chosen by the Centre for two months during the April-July period in the Indian Institute of Science (IISc), Bangalore, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bangalore or other institutions in the country.

Contact Address:

The Program Coordinator, SRFP,

Jawaharlal Nehru Centre for Advanced Scientific Research,

Jakkur P. O., Bangalore 560 064

Website : http://www.jncasr.ac.in/

Website of Opportunity: http://www.jncasr.ac.in/fe/F%20&%20E%20web%20-%20SRFP.htm

Email address: fellowships@jncasr.ac.in

Vaccine World Summit 2011- India

In India
Organizer:- www.imapac.com(NGO/Non-profit/Social enterprise)

Important Dates

Start Date: 1 March 2011

End Date : 3 March 2011
Eligibility:- Undergrad Level

Type of Opportunity:- Conference/Symposium

Vaccine World Summit India is the LARGEST and ONLY vaccine conference India to bring together Indian and international vaccine industry’s leading players, innovative biotechs, technocrats to showcase latest innovations from discovery to development, from manufacturing to delivery and formulation, and exchange ideas for new strategies and next generation technologies that help facilitate access to new vaccines both in the developing and the developed world, in order to combat global pandemic threats.

Visit the website to register.

Website : http://www.imapac.com/

Website of Opportunity: http://www.imapac.com/index.php?page=vaccineindia2011

COP10--Biodiversity / Japan's COP10 plan shows 'leadership'

NAGOYA--Japan's performance as host of the 10th Conference of the Parties to the Convention on Biological Diversity (COP10) in Nagoya has been "historical," CBD Executive Secretary Ahmed Djoghlaf said Friday, praising a last-ditch compromise proposed by Environment Minister and COP10 President Ryu Matsumoto as "living demonstration of leadership."
Djoghlaf spoke in an interview with The Daily Yomiuri soon after the release of a draft decision submitted by Matsumoto for a protocol concerning access and benefit-sharing (ABS) of genetic resources. Prepared in an effort to bridge the gap between still-divided parties on the final day of COP10, the draft included such changes as the removal from the main body of the text numerous disputed references to derivatives of genetic resources and the traditional knowledge of indigenous and local peoples.
However, it also agrees on the establishment of an intergovernmental committee for the ABS protocol that will conduct further negotiations on such issues as "measures to raise awareness of the importance of genetic resources and associated traditional knowledge, and related access and benefit-sharing issues."
"This is a package," the executive secretary said. "This is the draft, but you have a process to continue the negotiations. We cannot solve everything overnight; this is a very complex issue."
"Really, I want to pay tribute to Japan, whatever I can say to thank the government of Japan, the people of Japan," he said. "This text is a living demonstration of leadership."
Djoghlaf said he expected the COP10 parties to agree to the draft decision and had harsh words for any who might block it: "Whoever will disagree means that he doesn't want the protocol, because it's a fair compromise. Whoever will have an objection will bear a historical responsibility, because the person or the group or the country will be responsible for the failure."
"Instead of rushing and posing a decision which will never be implemented, or taking 20 years like the Law of the Sea to be ratified, this protocol will be ratified within two years, which is also part of the package," he said.
"We want to have the first COP-MOP [Meeting of the Parties to the Protocol] back to back with COP11, which will be historical. Meanwhile, we will have the signature of the protocol in New York on the 2nd of February, which will coincide with the launch of the [U.N.] International Year of Forests. The first meeting of the preparatory committee will be in June, not 2020: June next year."
A native of Algeria, Djoghlaf became executive secretary of the CBD in 2006, having previously served as assistant executive director of the U.N. Environment Programme.
He praised the efforts made by many different segments of Japanese society during the conference, including legislators and members of the business community. Among those Djoghlaf mentioned was Nagoya Mayor Takashi Kawamura for his part in the City Biodiversity Summit 2010, a gathering of leaders from more than 200 local authorities around the world, held concurrently with COP10 from Sunday to Tuesday.
Participants adopted a declaration that was submitted to the high-level segment of the conference, pledging support for their respective governments in implementing at the local level the objectives of the CBD and other multilateral environmental agreements related to biodiversity.
Djoghlaf also reiterated the economic value of safeguarding biodiversity, a key theme of the Nagoya conference. Until recently, he said, scientists or nongovernmental organizations met together and "preach[ed] among the converted that biodiversity is important. For the first time, we have also brought the other side of the problem, because the green aspect of biodiversity is known but the economic aspect is undermined."
"You can create a job for two or three years" by depleting natural resources, he said, "but the companies that are destroying the environment will close.
"The green economy takes time, but it's sustainable and it's long-term."
(Oct. 30, 2010)
Heather Howard / Daily Yomiuri Staff Writer

International Confrence on Cell Signaling And Diseases


OrganizerKIIT University(University)

Important Dates

Start Date: 29 October 2010

End Date : 30 October 2010

Eligibility Undergrad Level,Grad Level,Postgrad Level

Type of Opportunity

International Conference on "Cell Signaling and Diseases". Organized by KIIT School of Biotechnology,KIIT University, Bhubaneswar, Orissa, India.

The focus of the conference is to bring together academicians, researchers, students and practitioners under a common umbrella during the two-day meet, so that each one on the platform gains and understands the research needs and expertise of the other person, thus cultivating a culture of inter-institutional team work. The main focus will be on infection biology and emerging diseases, cell signaling, genomics, and proteomics. The conference program includes keynote address, invited talks and oral and poster presentation sessions

Call for Abstracts

Abstracts of original research work in the above mentioned and related areas are invited from scientists, postdoctoral and doctoral researchers worldwide to be considered for oral and poster presentations. Abstracts no longer than 500 words should be submitted in MS word and should include title, name(s) of the author(s) and preference as to the mode of presentation – oral or poster. Abstracts will be peer reviewed and the decision of the organizing committee shall be final. Posters should conform to the suggested size of 4’ X 3’ and include title (Capital letters, font Arial; size 12), author names (font Arial; size 12) with presenting author name underlined and address for communication (font arial; size 11). Once accepted, notification will be provided by email to the presenting author. The presenter must register for conference for paying the applicable registration fee.

Inaugural talk by Prof. Iain Mattaj

Director General

European Molecular Biology Laboratory (EMBL)

Heidelberg, Germany

Conference Secretariat

Dr. Mrutyunjay Suar, Conference Organizing Secretary,

KIIT School of Biotechnology (KSBT), Campus-11,

KIIT University, Patia, Bhubaneswar-751024, INDIA

Phone: +91 674 2725732, +91 9437011465 Fax: +91 674 2725732 for registration details visit this page http://www. kiitbiotech. ac. in/intcon/re. htm

Website : http://www.kiit.ac.in/
Website of Opportunity: http://www.kiitbiotech.ac.in/intcon/index.htm

RASA life Science Informatics

RASA Life Science Informatics, a bio-Chemoinformatics company based in Pune. Equipped with team members having a combined experience of more than 150 years, RASA is ready to set a new benchmark in providing services and solutions in the domain of bioinformatics, chemoinformatics and life science software development. RASA believes in sharing knowledge, hence we have a dedicated training division wherein students and professionals are trained.

Ø RASA is a pioneer in providing ’in demand ’ job & research oriented training & projects.

Ø RASA have successfully trained scientist and professionals from NCL, NARI , Persistent, Evolves, D Y patil, and other reputed national institutes & companies.

Ø RASA trained biochemistry, microbiology, biotech students in bio/ Chemoinformatics & pharmacoinformatics to enhance & optimize their research & publication work.

Ø RASA audience pool ranges from Junior college to PhD holders.

Ø 90% students get placed after training from RASA across India & abroad in various Pharma , biotech,CRO, institutes & companies like Xceleris, Evolvus, NCL & in RASA itself.

Ø RASA facilitate Corporate Training to reputed companies.

Why Industrial Training?

· To meet corporate/research need to get hire easily.

· To channelize efforts in right direction.

· To optimize knowledge and skills.

· To be out performer from day one on work.

Industrial Training & Projects Details :

RASA provide summer/winter/industrial training, certification courses and projects of duration 1 month to 6 months in field of Bioinformatics/Chemoinformatics & Biotech. Topics are as follows.

RASA‘s Exclusive training modules & projects topics :

v Micro-Array data Analysis,

v Protein Crystallography data Analysis

v Workflow Development

v QSAR studies

v in-Silico Primer designing and gene cloning

v virtual Library designing and scaffold hopping

v Life science software development

v Ligand based drug designing

v Structure based drug designing

v homology Modeling and Docking

v Bioinformatics

v Chemoinformatics /pharmacoinformatics


v Database Development

v Perl/Python/BioPerl/BioPython

v Life science portal/tool development

Biotech Training & Projects :

The project will have both Biotechnology and Bioinformatics topics, thus enabling you to have an increased level of understanding on your project. Duration is 6 months.

1. Industrial Training & project in Recombinant DNA Technology

2. Industrial Training & project in Cancer Cell Culture

Salient Features of RASA Training& Projects :

Ø We intent to restrict maximum number of students to 15 only.

Ø Chances to publish papers.

Ø Batches start every month.

Ø We conduct batches on week ends also.

Ø Guest lecture & guidance from eminent scientist from research institute of India and abroad.

Audience: Any one from junior college students, Diploma holders ,Graduates, Post-Graduates ,PhD holder, Teachers, scientist ,professional of science background like bioinformatics, chemistry, Pharma, biotech, microbiology, biochemistry etc. Those who want to meet industry standards.

Speakers: RASA teaching members are having experienced more than 50 years in industry and research organization. Some of RASA speakers are as follows:

National Speakers :

v Aftab Ahmed Khan (MD of RASA,5 yrs exp in Bio-&Chemoinformatics)

v Sapana Mehendale (M D, RASA,4 yrs exp in life science software development)

v Dr. Muthukumarasamy Karthikeyan (Scientist E1,NCL,15 yrs exp in Chemoinformatics & Drug Discovery Research)

v Dr. Rajesh Kumar Singh (Scientist,NCL,15 yrs exp in Molecular Biology, Biotech, protein crystallography )

v Dr. Syed Ismail Ahson (Pro VC, Patna University,55 yrs exp in Computer science Bio/Chemoinformatics)

v Pradeep Malji (Engineer, KSB Tech Pvt. Ltd, 4 years exp Software Design and Development, Technical Support)

v Saurabh Bundela (Senior Scientist, Systems Biology Worldwide,11 yrs exp in Genomics, proteomics, Bioinformatics)

v Vishal Rajdev(Senior S/w Executive, Thermax,6 yrs exp in Database management & ERP)

v Surojit Sadhu(Jr. Application Scientist, RASA,1.5 yrs exp in Bioinformatics/Chemoinformatics)

International Speakers:

v Dr.Alexander Tropsha(Professor and Chair UNC , USA, 26 yrs exp in Drug Discovery)

v Dr.Andreas Bender(Lecturer, University of Cambridge,UK,15 yrs exp in chemo/pharmacoinformatics)

v Dr.Santosh Panjikar(Scientist, EMBL-Hamburg, Germany,10 yrs exp in Protein crystallography )

v Dilip Narayana (Pursuing PhD ,Norway,5 yrs in Chemo-informatics)




RASA Life Science Informatics ,

opp Chitaranjan vatika, Model colony,Shivaji nagar,

Pune 411016.

Phone : 020 – 65600408,08007594458


Indo-US Research Fellowships

Indo-US Research Fellowships For Indian Researchers

In an effort to augment scientific excellence in erne rging areas of science and technology, the indo-US Science and Technology Forum (IUSSTF) In association with Science and Engl neering Research Council (SERC) of Department of Science and Technology (DST), announces the Indo-US Research Fellowships for the year 2011. The objective of the fellowship is to enable young researchers from India to carry out research in frontier areas of science and technology at a premier institution in USA. The fellowship will enable early and mid career Indian researchers to acquaint themselves with new scientific research methods and at the same time build strong collaborative linkages between the scientific communities of US and India.

Eligibility/ Application Requirements

Academic Qualifications

Master's Degree in Engineering, Technology or equivalent or Ph. D. In Science or Technology or equivalent or M. D. Degree in Medicine or equivalent Applicants must provide proof of independent research work in internationally recognized academic journals

Age : Upto 40 years as on 31 December 2010


A permanent position in a public funded R&D lab/ S&T institution (non-private)/ recognized universities/colleges in India
Areas covered under the Fellowship

* Atmospheric and Earth Sciences

* Chemical Sciences

* Engineering Sciences

* Life Sciences

* Medical Sciences

* Mathematical and Computational Sciences

* Physical Sciences

Promising applications in areas other than the above areas may also be considered
Place of work

The applicant should have letter of acceptance from reputed US scientific/technological institution where the applicant will be undertaking the research work under the Fellowship.

Fellowship Includes

• Monthly stipend

• Return airfare

• Preparatory allowances

• Conference allowances

Fellowship Duration

Minimum 3 months and upto 12 months


Dr. Smriti Trikha

Indo-US Science and Technology Forum

12 Hailey Road, Fulbright House, New Delhi-110 001

Website : http://www.indousstf.org/

Fee Of Biotecnology In Europe

Fee Of Biotecnology In Europe

Beasiswa Scholarships

Phd scholarship in Sociology for the year 2011 from googlecom; 3rd merit list of bsc engineering 2010 from googlecom; fee of biotecnology in europe from ...


Microbial biotecnology powerpoint download and Microbial

Microbial biotecnology powerpoint download and Microbial ...

Download microbial biotecnology powerpoint and Download microbial biotecnology ppt - on http://www.findtoyou.com./


Nanotech India 2010

Welcome to Nanotech India 2010 (19th - 21st November 2010 )

Nanotechnology has finally gained recognition in India. As an attempt to place India on the global Nanotechnology map, an Annual Conference and Business Meet in Nanotechnology begins today right here in Cochin, the commercial hub of the state of Kerala, from 19th–21st November 2010. Titled Nanotech India 2010, this conference is aimed at pulling together industry leaders, researchers, entrepreneurs and investors to create a platform for discussion on the issues and opportunities that are vital in commercializing Nanotech innovations. It is no wonder then that this conference has emerged as the premier nanotechnology research and business event in India.


workshop on Nanobioinformatics:Nano Goes insilico

The Bioinformatica Solutions of Lucknow based organization that is going to organize a three day workshop on:

Informatics explores"Room at the bottom":Nano Goes insilico

The Lectures will be delivered by the experts from different research center. Interested students can apply on

http://www.thebioinformatica.com/Registration.htm to get the full detailed information about the workshop.

2006 Wang Marine Biotecnology Discovery of the Genes in Response to White Spot Syndrome


International Conference on Emerging Frontiers and Challenges in HIV/AIDS Research

National Institute for Research in Reproductive Health (Indian Council of Medical Research) and Indian Society for the Study of Reproduction and Fertility Mumbai

The International Conference on “Emerging Frontiers and Challenges in HIV/AIDS Research” aims to provide an interactive forum to the researchers who have been engaged in addressing the cutting edge
researchable issues such as mode and mechanism of HIV infection and transmission; resistance to the pathogen as well as anti-HIV drugs; disease progression; and development of efficacious strategies for
prevention, diagnosis and treatment of HIV/AIDS.

The meeting will dwell on the key roadblocks to translational research in the field of HIV/AIDS which includes inconclusive knowledge of the basic mechanism of HIV pathogenesis, nature of the cellular and
anatomical reserviores of virus infection, limitation of non human primate models and lack of consensus in the appropriate models for vaccine research and product testing. Special sessions on the policymaking and advocacy for the programmes on control and management of HIV/AIDS will be the other highlights of this international meet.

This meeting is expected to create an excellent convergence of the perspectives of those with specific interests in fundamental, clinical and sociobehavioural research on HIV/AIDS. We earnestly hope that the deliberations during the conference will help in translating theoretical advances into the clinical practices and contribute towards deaccelerating the pace of this pandemic.

The scientific programme will include plenary lectures, lectures from invited speakers and oral /poster sessions covering the following major themes

Basic Research

Clinical Research

Socio-behavioral Research

Submission of Abstract

The abstract of about 300 words typed on a plain paper using Microsoftword (12pt,Times New Roman) to be sent by email to the Organizing Secretary by

November 30,2010

UCD team discovers genetic link to blood clots

Research reveals genetic markers which identify why some people are prone to heart attacks

IRISH SCIENTISTS have spearheaded a major breakthrough in understanding why some people are more prone to developing potentially fatal blood clots.

A team from the Conway Institute at University College Dublin, working in collaboration with a Europe-wide consortium, has uncovered a series of genetic markers which identify people at risk of excessive clot formation and heart attack.

The research, published in the leading haematology journal Blood , is predicted to advance radically the detection and treatment of coronary artery disease (CAD), the most common cause of premature death in Ireland.

Heart attacks normally arise from clots in the coronary artery. The clotting mechanism is initiated by platelets, tiny cellular particles that float in the bloodstream. When bleeding occurs, chemical reactions change the surface of the platelets to make them sticky, enabling them to fuse together on the surface of blood cells and form a clot.

It has long been observed that the level of platelet activity and clot formation vary considerably from person to person, partly as a result of their genetic make-up.

As part of the European Union’s Bloodomics project, the UCD team investigated the complex genetic pathways involved in platelet activity to understand better how they are involved in heart disease. The team managed to link, for the first time, a number of the 60 or so genetic variants associated platelet activity to an increased risk of heart attack.

“Essentially, we have found the genetic traits that promote clot formation in people who have a history of heart disease,” said biochemist Dr Patricia Maguire, who jointly led the UCD team’s work alongside professor of molecular medicine and vice-president for research at the university, Desmond Fitzgerald.

Identifying the at-risk category at an early stage should enable doctors to prevent people developing CAD through lifestyle changes and/or medication, she said.

Separate from the research, published this month, the UCD team has also uncovered a specific pathway, not observed before, which dampens down platelet activity.

While anti-clotting drugs such as aspirin have been used by physicians to treat people at risk from heart attack since the 1980s, the drugs do not appear to work on a significant subset of patients. Dr Maguire believes the discovery of a specific pathway which lessens platelet activity may play an important role in the development of new drugs to treat heart disease.

According to figures from the Irish Heart Foundation, cardiovascular disease, which includes CAD and stroke, is the principal cause of mortality in more than 35 per cent of all Irish deaths – about 10,000 lives every year. CAD accounts for nearly half of these deaths, making it the single biggest cause of mortality in Irish men and women.

The UCD team’s research was funded jointly by the European Union and Irish Health Research Board.

Daksh 2010,Social B-Plan Contest,IIFM Bhopal

2 week left!!!

Orgainsed by:- Indian Institute of Foreign Management

Start Date: 13 November 2010

End Date : 13 November 2010
Deadline: 14 October 2010

Eligibility for  Competition/Contest:- Grad Level,Postgrad Level

Indian Institute of Forest Management is a premier sectoral management Institute, which aims at carving out socially responsible managers. The Entrepreneurship Development Cell (EDC), IIFM is organizing a National level Entrepreneurship Summit and DAKSH-10 the Social Business Plan competition on 13th November 2010. Summit will see the participation from well renowned personalities from the field of banking and development and Entrepreneurs discussing their path to success.

We are inviting entries for the Social B-Plan competition.

The participants can choose the area of their interests. Some of the suggested areas are:

 Agribusiness

 Clean/Green Energy

 Eco-Tourism

 Information and Communication Technology (ICT) in Rural Development

 Rural Enterprise Development  Marketing and Supply Chain management

 Any other idea which shows a societal perspective

Size of team: 1 or 2 Management graduates, Engineering graduates and start-ups are eligible to participate

Last date of Registration and submitting Executive Summary is 14th Oct, 2010.

Register at: www. edciifm. com/registration
Prizes worth Rs. 50,000 to be won For more details logon to http://www.%20edciifm.%20com/


Bio technology is a new term evolved in the 20 the century. It is the scientific manipulation of living organism for human benefit and its best known form is genetic engineering, industrial agriculture, plant breeding, animal breeding are the backgrounds of biotechnology. In simple biotechnology brings together technology with the science of the living cells. This paper is focused on the role of patents in the area of Biotecnology, an important tool to protect Biotechnological inventions


Trips that came into force in 1995, provides the minimum standard of patent protection that requires mandatory compliance by all the member countries.Art.27 (3) (b) of TRIPS states that members may also exclude from patentability: plants and animals other than micro-organisms, and essentially biological process for the production of plants and animals other than micro-organisms, and essentially biological process for the production of plants and animals other than non-biological and micro-biological process.However,members shall provide for the protection of plant varieties either by patent or by an effective sui-generis system or by any combination thereof.

The patent protection is obtainable for most of the bio-technological innovations. The protection thus provided serves as an incentive for the further development and technical innovations. Accepting the traditional approach the new premise of patent law state that natural life is the creation of god but the non natural life is the creation of human being. So the new idea of patent law is that creation of god or the creation of the nature could not be patented, where as creations of man which involves the applications of human intelligence to natural things could be patentable.

Art 27 of the TRIPS Agreement forms the basis for the provisions on the patentability of micro-organism. Nevertheless, micro-organisms also have to satisfy the novelty, utility and non-obviousness criteria to be patentable. However, TRIPS agreement does not provide a precise definition of the term micro-organism. The term is generally understood to include viruses, bacteria, yeast and other forms of fungi Protozoa and unicellular algae and non differentiated animal or plant cells. Even though micro-organisms can be patented as per TRIPS agreement; one is often faced with a dilemma whether at all micro-organism constitute a patentable subject matter since they are real life forms.
                                                      The law which opened the gates for inventions in the field of biotechnology, particularly in micro organism, was a land marked judgement of the US Supreme Court in 19809 in diamond v.chakaravarty.The dispute was with regard to a modified micro organism developed by the Anada Chakravarty which has the ability of breaking down the crude oil. This property introduced into the naturally occurring bacterium to produce a genetically modified organism. The commissioner of patent in the US field held that the subject matter of the invention was a living organism and was hence not patentable. The US Supreme Court judge, however, decided in favour of the patentee and stated that everything under sun is patentable. The landmark judgement paved the way for the grant of a number of such biotechnology related patents.
                          In India the position of patentability of the micro-organism is parallel to that of the UK and Europe. The Calcutta high court gave a path breaking judgement in the case of dimminico A.G v.controller of patents and designs which has been hailed in the Indian counter to Diamond V.Chakravarty of the U.S.A.The case related to the patentability of a process for preparation of bursitis vaccine useful for the protecting poultry against the infectious bursities.The ground for rejection of the patent by the controller was that the examiner found that the claim did not fall within sec.2(1)(j) of Indian patent Act,1970 and therefore is not an invention. The court held that ‘merely because the end product of process contains a living organism does not preclude the process from being an invention and consequently patentable.”Further, the court found that the patent claimed was useful as it protected poultry against contagious disease and the end product resulted in a new article.

The TRIPS agreement provides that the member states may exclude plants and animals from patentability. This option has been adopted by a number of countries such as the United Kingdom, Europe and India. The issue of the patentability of animals arises mainly because the patentability of animals is considered to be moral issue rather than a legal one. In India the plant varieties may be protected under the protection of Plant Varieties and Farmer’s       Rights act. This act will come into force soon for the protection of plant variety as it is a requirement under the TRIPS agreement. Inventions which concern plants and animals may be patentable if the technical feasibility of the invention is not confined t o a particular plant or animal variety. The onco-mouse case showed that the exclusion is confined to varieties of animal alone. The EPO applied examinee of animals which subdivides a species into subspecies and varieties. Varieties constitute the lowest sub-division .although the invention was to be applied to mice, any non-human mammal was claimed .As this did not confine the claims to a variety, the patent was granted.
Another aspect which is important to consider under biotechnology is patentability of genes and DNA sequences. Genetic inventions encompasses medical. Agricultural environmental and industrial application patenting of genes would be essential since it would provide an incentive for the manufacture of new and important therapeutic drugs and its application in different areas of biotechnology. The trend of granting patent on non-natural loving being took an interesting turn which claims patent on human genetic material. In john Moor’s case, patent was granted to cell lines of human beings useful in producing cancer fighting protein, followed by patent on human genetic materials like D NA and RNA in amezen Ins vs. Chuga Pharmaceuticals. After this case, European patent office also started granting patents on human genetic material. So it through many case laws that DNA, RNA and human cells could be patented. At the same time it was also made clear that human beings though genetically engineering or none naturally produced could not be patented.

 Non natural or genetically modified living beings are the results of non natural and genetically modified biological processes. Addition of human intelligent to the natural processes renders it non natural. Since patents are available to the products as well as processes, so the task ahead for the inventor of the biological processes was to convince the patent office that biotechnological processes are non natural and there is a role of human agency which differentiate a human process and natural process. In Hybertech Inc Vs Monoclonal Antibodies Inc, a patent was claimed for process of utilising protein to fight against the diseases. The inventors convinced the court that the method is non natural process. Since it utilise proteins produced inside the body on human prescription and obtained patent.
The current trend in the patent however states that the non natural life, living beings and non natural living processes are patentable. Biotechnological processes and micro biological processes are non natural processes which involve addition of human intelligence to the natural process in producing none natural and genetically modified living beings. The inventions of biotechnology ranges from non natural micro organisms like bacteria plasmid, non natural plant, non natural animal and non natural human genetic material which are undoubtedly patentable. Besides, biotechnological process could also be patented in the upsurge of the new period in patent law.